1. Baxter AJ, Scott KM, Vos T, Whiteford HA. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med 2013;43:897–910.
3. Parker GB, Brotchie H, Graham RK. Vitamin D and depression. J Affect Disord 2017;208:56–61.
4. Wood JM, Gupta S. Vitamin D and neurocognitive disorder due to Alzheimer’s disease: A review of the literature. Ann Clin Psychiatry 2015;27:e1–e7.
5. Belvederi Murri M, Respino M, Masotti M, Innamorati M, Mondelli V, Pariante C, et al. Vitamin D and psychosis: mini meta-analysis. Schizophr Res 2013;150:235–239.
6. Jia F, Shan L, Wang B, Li H, Miao C, Xu Z, et al. Bench to bedside review: possible role of vitamin D in autism spectrum disorder. Psychiatry Res 2018;260:360–365.
7. Neighbors CLP, Noller MW, Song SA, Zaghi S, Neighbors J, Feldman D, et al. Vitamin D and obstructive sleep apnea: a systematic review and meta-analysis. Sleep Med 2018;43:100–108.
8. Armstrong DJ, Meenagh GK, Bickle I, Lee AS, Curran ES, Finch MB. Vitamin D deficiency is associated with anxiety and depression in fibromyalgia. Clin Rheumatol 2007;26:551–554.
9. de Koning EJ, Verweij L, Lips P, Beekman ATF, Comijs HC, van Schoor NM. The relationship between serum 25(OH)D levels and anxiety symptoms in older persons: results from the Longitudinal Aging Study Amsterdam. J Psychosom Res 2017;97:90–95.
11. Colotta F, Jansson B, Bonelli F. Modulation of inflammatory and immune responses by vitamin D. J Autoimmun 2017;85:78–97.
12. Glaus J, von Kanel R, Lasserre AM, Strippoli MF, Vandeleur CL, Castelao E, et al. The bidirectional relationship between anxiety disorders and circulating levels of inflammatory markers: Results from a large longitudinal population-based study. Depress Anxiety 2018;35:360–371.
13. Naude PJW, Roest AM, Stein DJ, de Jonge P, Doornbos B. Anxiety disorders and CRP in a population cohort study with 54,326 participants: the LifeLines study. World J Biol Psychiatry 2018;19:461–470.
15. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448–454.
17. Jung IK. Prevalence of vitamin D deficiency in Korea: Results from KNHANES 2010 to 2011. J Nutr Health 2013;46:540–551.
18. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clinic Proc 2011;86:50–60.
19. Kwon SM, Oei TP. Differential causal roles of dysfunctional attitudes and automatic thoughts in depression. Cogn Ther Res 1992;16:309–328.
20. Lee HK, Lee EH, Hwang ST, Hong SH, Kim JH. Psychometric properties of the Beck Anxiety Inventory in the community-dwelling sample of Korean adults. Korean J Clin Psychol 2016;35:822–830.
21. Yook S, Kim Z. A clinical study on the Korean version of Beck Anxiety Inventory: comparative study of patient and non-patient. Korean J Clin Psychol 1997;16:185–197.
22. Beck AT, Epstein N, Brown G, Steer RA. An inventory for measuring clinical anxiety: psychometric properties. J Consult Clin Psychol 1988;56:893
23. Lee B, Lee C, Lee P, Choi M, Namkoong K. Development of Korean version of alcohol use disorders identification test (AUDIT-K): Its reliability and validity. J Korean Acad Addict Psychiatry 2000;4:83–92.
24. Wortsman J, Matsuoka LY, Chen TC, Lu Z, Holick MF. Decreased bioavailability of vitamin D in obesity. Am J Clin Nutr 2000;72:690–693.
25. Eyles DW, Smith S, Kinobe R, Hewison M, McGrath JJ. Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain. J Chem Neuroanat 2005;29:21–30.
26. Kalueff AV, Lou YR, Laaksi I, Tuohimaa P. Increased anxiety in mice lacking vitamin D receptor gene. Neuroreport 2004;15:1271–1274.
27. Patrick RP, Ames BN. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism. Faseb J 2014;28:2398–2413.
28. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Ann Rev Nutr 2003;23:117–145.
30. Michopoulos V, Powers A, Gillespie CF, Ressler KJ, Jovanovic T. Inflammation in fear- and anxiety-based disorders: PTSD, GAD, and beyond. Neuropsychopharmacology 2017;42:254–270.